Omeprazole Magnesium Acid Reducer Capsules Recalled for Staple Contamination
Dr. Reddy's Laboratories is recalling Acid Reducer (Omeprazole Magnesium) 20 mg capsules nationwide because staples have been found co-mingled with capsules in bottles.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: This is an FDA Class II recall involving a manufacturing defect (staple contamination). No reported illnesses or injuries are stated in the source text. The hazard is a foreign object contamination, which is a documented quality control deviation but without evidence of actual harm or hospitalization, placing it in the Moderate category.
Plain-English summary
Dr. Reddy's Laboratories, Inc. is recalling Acid Reducer (Omeprazole Magnesium) Delayed-Release Capsules, 20 mg, 24-hour strength, in 14-count bottles. The recall was initiated due to a customer complaint reporting the presence of a staple co-mingled with capsules within the bottle, indicating a manufacturing defect.
The affected product was distributed nationwide in the USA. The recalled product is identified by the batch code BT001594C, NDC 70000-0232-1, and approximately 8,976 bottles are involved in this recall. The product was distributed by Cardinal Health, Dublin, OH.
Consumers who have purchased this product and have the affected batch code should not use it and should contact Dr. Reddy's Laboratories or a healthcare provider if they have questions or concerns.
The recalled product
- Product
- ACID REDUCER (OMEPRAZOLE MAGNESIUM)
- Brand
- ACID REDUCER
- Manufacturer
- Dr. Reddy's Laboratories, Inc.
- Hazard
- foreign-object-contamination
- staple-in-capsules
- manufacturing-defect
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- BT001594C
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled for Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27